US Patent 10787518 Bispecific checkpoint inhibitor antibodies
Patent 10787518 was granted and assigned to Xencor on September, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10787518 Bispecific checkpoint inhibitor antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.